Keyword search (4,164 papers available)

"Safety" Keyword-tagged Publications:

Title Authors PubMed ID
1 Impact of COVID-19 on incidence and trends of adverse events among hospitalised patients in Calgary, Canada: a retrospective chart review study Wu G; Eastwood CA; Cheligeer C; Southern DA; Zeng Y; Ghali WA; Bakal JA; Boussat B; Flemons W; Forster A; Xu Y; Quan H; 41592994
CONCORDIA
2 Leading the way to a safer workplace: What enables supervisors to be servant leaders and enhance subordinates workplace safety behaviors? Chen YP; Hsu YS; Panaccio A; Wang H; 40483067
JMSB
3 The false promise of return to work for migrant workers injured on the job in Canada: When public policies intersect to create exclusion Hanley J; Ventura Sanchez G; Goswami P; Mayell S; McLaughlin J; Hennebry J; 40223307
SOCANTH
4 Effect of age on hypnotics' efficacy and safety in insomnia: A systematic review and meta-analysis Patrick Viet-Quoc N; Thien Thanh DV; Philippe L; Sebastien C; Lidia S; Philippe D; 39603114
CONCORDIA
5 Feeling safe: a critical look at the effect of neighborhood safety features and perceptions on childhood symptoms of depression Infantino E; Barnett TA; Côté-Lussier C; Van Hulst A; Henderson M; Mathieu ME; Sabiston C; Kakinami L; 39604905
SOH
6 Supporting pregnant and parenting women who use alcohol during pregnancy: A scoping review of trauma-informed approaches Morton Ninomiya ME; Almomani Y; Dunbar Winsor K; Burns N; Harding KD; Ropson M; Chaves D; Wolfson L; 36744547
CONCORDIA
7 Microfluidics in smart packaging of foods Pou KRJ; Raghavan V; Packirisamy M; 36192908
ENCS
8 Survey of Cooperative Advanced Driver Assistance Systems: From a Holistic and Systemic Vision González-Saavedra JF; Figueroa M; Céspedes S; Montejo-Sánchez S; 35459025
ENCS
9 Measuring workplace psychosocial factors in the federal government Blais AR; Michaud I; Simard JF; Mach L; Houle S; 35044739
CONCORDIA

 

Title:Effect of age on hypnotics' efficacy and safety in insomnia: A systematic review and meta-analysis
Authors:Patrick Viet-Quoc NThien Thanh DVPhilippe LSebastien CLidia SPhilippe D
Link:https://pubmed.ncbi.nlm.nih.gov/39603114/
DOI:10.1016/j.sleep.2024.11.023
Publication:Sleep medicine
Keywords:AgedChronic insomniaDrug efficacyDrug safetyMeta-analysisSleep initiation and maintenance disorders
PMID:39603114 Category: Date Added:2024-11-28
Dept Affiliation: CONCORDIA
1 Montreal University Hospital Centre Research Centre, 900 Rue Saint-Denis, Montreal, Quebec, H2X 0A9, Canada; Quebec Network for Research on Aging, 4565 Queen-Mary Road, Montreal, Quebec, H3W 1W5, Canada. Electronic address: patrick.nguyen@umontreal.ca.
2 Centre de recherche de l'institut universitaire de gériatrie de Montréal (CRIUGM), CIUSSS Centre-Sud-de-l'île-de-Montréal, 4565 Chem. Queen Mary, Montréal, QC H3W 1W5, Canada; Concordia University, 1455 De Maisonneuve Blvd. W, Montreal, Quebec, H3G 1M8, Canada.
3 Montreal University, 2900, boul. Édouard-Montpetit, Montréal, Quebec, H3T 1J4, Canada.
4 Montreal University Hospital Centre Library, 1000, rue Saint-Denis, Montréal, Québec, H2X 0C1, Canada.
5 Montreal University Hospital Centre Research Centre, 900 Rue Saint-Denis, Montreal, Quebec, H2X 0A9, Canada.

Description:

Objective: This systematic review and meta-analysis evaluates the efficacy in improving sleep quality and safety of hypnotics in individuals aged 65 years or older compared to those under 65 years.

Methods: MEDLINE, EMBASE, Web of Science, and EBM Reviews were searched for randomized clinical trials comparing hypnotics to the placebo in adults with chronic insomnia between Jan 2000 and Dec 2022. The efficacy outcome included all participant self-assessments sleep quality questionnaires. The safety outcome included acceptability and tolerance. Standardized mean differences (SMD) was estimated using a random effect model.

Results: We included 17 and 53 clinical trials with 3688 and 14,720 participants in the =65 years and <65 years group respectively. The SMD for the sleep quality outcome was -0.36 [Confidence interval (CI) 95 %: 0.45; -0.26] in the =65 years group compared to -0.51 [95%CI: 0.61; -0.41] in the <65 years group (p = 0.02). Differences in efficacy were observed between pharmacological classes. The overall SMD for the tolerance outcome was - 0.25 [95%CI: 0.34; -0.16] favoring the placebo group (p < 0.001). In the =65 years group the SMD was -0.07 [95%CI: 0.21; 0.08] compared to -0.31 [95%CI: 0.41; -0.21] in the <65 years group (p = 0.01). There were no differences for acceptability.

Conclusion: We found that some hypnotics classes could be less effective in older individuals. We encourage authors to include details on multimorbidity and polypharmacy in their publications.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University